NCT07367412 Zinc Supplementation and Infections in Older Medical Patients
| NCT ID | NCT07367412 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Herlev Hospital |
| Condition | Older Adults (65 Years and Older) |
| Study Type | INTERVENTIONAL |
| Enrollment | 8,000 participants |
| Start Date | 2026-02-01 |
| Primary Completion | 2028-03-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 8,000 participants in total. It began in 2026-02-01 with a primary completion date of 2028-03-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn about the effect of zinc supplementation once daily for 12 months in older acute medical patients. The main question it aims to answer is: • Can daily zinc supplementation for 12 months increase Days Alive and Out of Hospital (DAOH)? Researchers will compare zinc supplementation to a control group, a group who do not receive zinc supplementation, to see if zinc supplementation can increase Days Alive and Out of Hospital, reduce antibiotic use, readmissions and mortality. Participants will take 22 mg zinc supplementation once daily for 12 months or not. The researchers will draw data on readmissions, antibiotic use and mortality during the 12 months follow-up period.
Eligibility Criteria
Inclusion Criteria: * All medical patients aged ≥ 65 years assessed at the Medical Emergency Department, Herlev Hospital Exclusion Criteria: * Self-supplementing with zinc at time of assessment (\> 10 mg zinc/day) * Terminal illness (life expectancy \< 6 months, estimated by Clinical Frailty Scale ≥8) * Patients receiving parenteral nutrition (partial or complete) * Patients treated with hemodialysis or peritoneal dialysis * Patients know with known severe dementia * Patients who do not understand Danish and patients with temporary civil person registration numbers (CPR)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07367412 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Older Adults (65 Years and Older). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07367412 currently recruiting?
Yes, NCT07367412 is actively recruiting participants. Contact the research team at cecilia.margareta.lund@regionh.dk for enrollment information.
Where is the NCT07367412 trial being conducted?
This trial is being conducted at Herlev, Denmark, Herlev, Denmark.
Who is sponsoring the NCT07367412 clinical trial?
NCT07367412 is sponsored by Herlev Hospital. The trial plans to enroll 8,000 participants.